Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 901–1,000 of 1,000
Screening candidate genes associated with bladder cancer using DNA microarray
Xu, A., Wang, C., & Sun, S. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2667 · Cited by 3
“Transcriptional regulation of cyclin D has been extensively investigated and is well understood (25-27).”
Leroux, M., Boutchueng-Djidjou, M., & Faure, R. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031030 · Cited by 4
“In marked contrast with Cdk2, which is not considered essential on the basis of non-lethality in the mouse model [75], the metabolic enzyme ATIC, an important node in the T2D disease module [22,86], is an example of a highly conserved enzyme present in prokaryotes but not considered essential in terms of lethality in…”
BackgroundRole of RUNX3 in Restriction Point Regulation
Lee, J.-W., Lee, Y., Kim, M., Chi, X., Kim, D., & Bae, S. (2023) · Cells · doi:10.3390/cells12050708 · Cited by 3
EEF1E1 promotes glioma proliferation by regulating cell cycle through PTEN/AKT signaling pathway
Wang, H., Han, R., Li, Q., Kang, W., Dong, Q., Yin, H., Niu, L., Dai, J., Yan, Y., Su, Y., et al. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23611 · Cited by 3
“Normal cell cycle progression relies on tight regulation of cyclin activity through cell cycle‐specific transcription and protein degradation mechanisms.(33) Dysregulation of these mechanisms is frequently observed in human cancers, leading to aberrant activation of cyclins and genetic damage within the core cell cycl…”
BackgroundAli, B. M., El-Abhar, H. S., Abdallah, D. M., Mohamed, G., Sharaky, M. M., Shouman, S. A., & Kamel, M. (2023) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.7416 · Cited by 3
Role of Signaling Pathways Regulating Cell Cycle Progression in Cancer
Nabi, N., Nisa, M. U., Khan, M. S., & Gillani, S. Q. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_12 · Cited by 5
Hypoxic Pulmonary Vascular Smooth Muscle Cell Proliferation
Mizuno, S., Toga, H., & Ishizaki, T. (2012) · InTech eBooks · doi:10.5772/45979 · Cited by 3
“cell proliferation [20].”
Is there a role for diacylglycerol kinase-ζ in cell cycle regulation?
Los, A. P., de Widt, J., BLITTERSWIJK, W. J. V., & Divecha, N. (2008) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2008.02.001 · Cited by 3
Lou, H.-P., Gao, Y., Zhai, M., Qi, Y., Chen, L., Lv, H., Yu, J., & Li, Y. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.017 · Cited by 3
Zhang, W. (2006) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20060410 · Cited by 3
Xin, C., Zhao, C., Yin, X., Wu, S.-L., & Su, Z. (2016) · Hematology · doi:10.1080/10245332.2015.1101978 · Cited by 3
Maintenance of Leukemia-Initiating Cells Is Regulated by the CDK Inhibitor Inca1
Bäumer, N., Bäumer, S., Berkenfeld, F., Stehling, M., Köhler, G., Berdel, W. E., Müller‐Tidow, C., & Tschanter, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115578 · Cited by 3
“The complex network of cell cycle regulation encompasses a high degree of compensatory features in most cell types [8, 11].”
BackgroundRenal Hyperplasia and Hypertrophy
Brinkkoetter, P. T., Griffin, S., & Shankland, S. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00028-8 · Cited by 3
Cancer RNome: Evolution and Sustenance
Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_3 · Cited by 4
Quantifying E2F1 protein dynamics in single cells
Mathey-Prévôt, B., Parker, B., Im, C., Hong, C. S., Dong, P., Yao, G., & You, L. (2020) · Quantitative Biology · doi:10.1007/s40484-019-0193-6 · Cited by 3
“Its inhibition is specifically relieved during the G1 phase through hyper-phosphorylation by G1 cyclins/CDK complexes [5,6].”
BackgroundG1/S Transition and the Rb-E2F Pathway
Shen, W. (2007) · Plant cell monographs · doi:10.1007/7089_2007_122 · Cited by 3
“This contrasts the situation in mammalian cells where the specific CDK4 and CDK6 bind cyclin D, and CDK2 binds cyclin E and cyclin A, which together control G1/S transition and S phase progression ( Sherr and Roberts 2004 ).”
BackgroundCDK4 loss-of-function mutations cause microcephaly and short stature
Schlie, A. V., Leitch, A., Arismendi, M. I., Stok, C., Leal, A. D. C., Parry, D. A., Lerário, A. M., Harley, M. E., Freire, B. L., Carroll, P. L., et al. (2025) · Genes & Development · doi:10.1101/gad.352311.124 · Cited by 3
“Cyclin-dependent kinase 4 (CDK4) and CDK6 are functionally redundant regulators of G1 progression and the G1/S transition (Matsushime et al. 1994; Kato 1999; Sherr and Roberts 2004).”
Characterization of cyclin-dependent kinases and their expression in developing maize endosperm
Dante, R. A. (2005) · UA Campus Repository (The University of Arizona) · Cited by 3
Cyclosporine A causes gingival overgrowth via reduced G1 cell cycle arrest in gingival fibroblasts
Takeuchi, R., Nomura, T., Yaguchi, M., Shinozaki‐Kuwahara, N., Amino, Y., Taguchi, C., Suzuki, I., Suzuki, H., Nagashima, T., Arikawa, K., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309189 · Cited by 2
Sun, L., Li, Y., Zhang, H., Chen, X., Yang, G., & Xu, S. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf159 · Cited by 2
Targeting pantothenate kinases in human diseases: Biochemistry and pharmacotherapy
Zhang, X., Zhang, B., Li, X., Qiu, F., Zhang, Q., & Kang, N. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117207 · Cited by 4
Implications of canonical histone H3.1 and histone variant H3.3 in cancer
Wu, P., Wang, L., Wen, T., & Chen, Q. Y. (2025) · Open Biology · doi:10.1098/rsob.250133 · Cited by 2
“Given the critical role of cyclin D1 in the G1 to S cell cycle transition, the researchers examined the effects of DAXX silencing on cell-cycle progression and observed that DAXX silencing induced cyclin D1-mediated G1 arrest in OSCC cells [62,120,121].”
Zhu, J., Hu, N., Chi, Y.-J., Lai, X.-H., & Song, Y.-F. (2025) · Aquaculture International · doi:10.1007/s10499-025-02244-w · Cited by 2
“Consequently, a growing body of research has been conducted to elucidate the beneficial effects of dietary phospholipid supplementation on ovarian development in broodstock fish (Jiang et al. 2024a; Watanabe et al. 1991; Zhang et al. 2010).”
InfluentialSARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses
Singh, E., Nishi, N., Tripathi, M., & Prakash, K. S. (2025) · Reviews in Medical Virology · doi:10.1002/rmv.70094 · Cited by 2
Wang, X., Sheng, N., Luo, F., Jia, G., Wang, A., Lu, D., Li, Z., Li, J., Tan, H., & Zhao, G. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504662 · Cited by 2
“Abnormal changes in TNF-α and IL-10 are often associated with both acute and chronic inflammation [58, 59].”
Elsayed, D. A., Shehab, W. S., Mohamed, M. M., Mesbah, A. E., El‐Bassyouni, G. T., Mousa, S. M., Elenin, O. M. A., Assy, M. G., & Tantawy, E. S. (2026) · Drug Development Research · doi:10.1002/ddr.70322 · Cited by 2
“…groups, (ii) heterocyclic ring systems, (iii) hydrophobic substituents, and (iv) stereochemistry of the compounds, all of which contribute to improved binding affinity and anticancer activity (Al‐Hussain et al. 2025; Otto and Sicinski 2017; Sherr and Roberts 2004; Zhang et al. 2009).”
Luo, L., Kang, M., Liua, K., Guo, X., & Xu, B. (2012) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2012-5-615 · Cited by 2
Cyclin D1, Metabolism, and the Autophagy-Senescence Balance
Valenzuela, C. A., & Brown, N. E. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_5 · Cited by 2
A stochastic model of adult neurogenesis coupling cell cycle progression and differentiation
Stopka, A., & Boareto, M. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.05.014 · Cited by 2
Mir, M. A., & Sofi, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_4 · Cited by 4
Rock, A. G., Uche, A., Yoon, J. M., Agulnik, M., Chow, W. A., & Millis, S. Z. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13101499 · Cited by 2
“Subsequent phosphorylation of RB, a cell cycle regulator, medi-J ates cell cycle progression after dissociating from G1 to S phase-promoting transcription factors [65,66].”
BackgroundLiu, Q., Zhao, X., Shao, X., Cheng, P., Cui, J., & Han, S. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23811 · Cited by 2
Yoshioka, H., Horita, H., Tsukiboshi, Y., Kurita, H., Ogata, A., & Ogata, K. (2025) · Non-Coding RNA · doi:10.3390/ncrna11010012 · Cited by 2
Mitotic regulation of CDK4 by the serine/threonine phosphatase, calcineurin
Chow, R. S., Olesen, J. D., Onyskiw, C., & Baksh, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.197 · Cited by 2
G1 Phase Cyclins in Cancer Development and Progression
Alao, J. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_9 · Cited by 2
Mechanisms of Cell Cycle Regulation by TGF-β Disabled in Cancer
Gold, L. I., & Lecanda, J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-292-2_14 · Cited by 3
RNA Interference of Biot2 Induces G1Phase Arrest and Apoptosis in Mouse Colorectal Cancer Cell Line
Zhou, C., Zhang, P., Xu, G., Wu, D., Liu, R.-Y., Zeng, Q., & Wang, C. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x14146137738583 · Cited by 3
Hyper sensitive protein detection by Tandem-HTRF reveals Cyclin D1 dynamics in adult mouse
Zampieri, A., Champagne, J., Auzemery, B., Fuentes, I., Maurel, B., & Bienvenu, F. (2015) · Scientific Reports · doi:10.1038/srep15739 · Cited by 2
4-Nerolidylcatechol induces autophagy in human glioblastoma cells
Massaro, R. R., Brohem, C. A., de Almeida, R. L., Rivelli, D. P., Miyake, J. A., Colquhoun, A., Barros, S. B. D. M., & Maria–Engler, S. S. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000300169 · Cited by 3
Tillu, H., & Bramhachari, P. V. (2017) · Springer eBooks · doi:10.1007/978-981-10-6728-0_37 · Cited by 2
Barbash, O., & Diehl, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10013-5 · Cited by 4
Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes
Banday, M. Z., Aga, S. S., & Nissar, S. (2021) · Springer eBooks · doi:10.1007/978-981-33-6699-2_5 · Cited by 2
Divya, V., & Pushpa, V. L. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.108020 · Cited by 4
Lian, J. B., & Stein, G. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50007-x · Cited by 4
Mathkor, D. M., Madkhali, N. A. B., MANDAL, R. K., Dailah, H. G., Areeshi, M. Y., & Haque, S. (2024) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.24.02940-7 · Cited by 2
The Retinoblastoma Tumour Suppressor
Dirlam, A., & Macleod, K. F. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap224 · Cited by 2
Shah, S. P. (2016) · San José State University ScholarWorks (San Jose State University) · doi:10.31979/etd.32pr-8xtr · Cited by 2
The Smad3 linker region: transcriptional activity and phosphorylation-mediated regulation
Wang, G. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3v1256q · Cited by 2
Yang, K., Chen, G., & Wang, X. (2020) · Medical Science Monitor · doi:10.12659/msm.920784 · Cited by 1
“In the M phase, chromosomes segregate, providing a template for the synthesis of more strands [12,13].”
BackgroundLinc01124 promotes hepatoblastoma proliferation through the miR-24-3p/PI3K/AKT pathway
Wu, Z., Chen, S., Zuo, T., Fu, J., Gong, J., Liu, D., & Wang, B. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101910 · Cited by 1
Khoshkenar, T., Mashayekhi, F., Mottaghi, M., & Salehi, Z. (2025) · Veterinarska stanica · doi:10.46419/vs.56.5.8 · Cited by 1
Murata, M., Marugame, Y., Yamada, S., Lin, I.-C., Yamashita, S., Kumazoe, M., Fujimura, Y., & Tachibana, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-15588-3 · Cited by 1
“The cyclin D1 protein encoded by the CCND1 gene is a key molecule of physiological cell cycle regulation 28 .”
Wan, H., Zhou, H., Gui, J., Yang, D., Wang, R., Jiang, N., Wu, S., Yan, Q., Qi, Q., Zhu, L., et al. (2025) · Oncology Letters · doi:10.3892/ol.2025.15295 · Cited by 1
“The growth factor‑mediated accumulation of D‑type cyclins in cells further induces CDK4/6 activity and maintains the cell cycle (74), which initiates the phosphorylation/inactivation of the RB tumor suppressor and blocking the RB‑mediated negative regulation of cell cycle transition and DNA…”
Hodgson, J. T., Butler, L. M., & Centenera, M. M. (2026) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-25-1270 · Cited by 1
Clinicopathologic characterization of plasma cell neoplasms with IGH :: CCND3
Padmanabha, N., Sperling, A. S., Morgan, E. A., Michaels, P. D., & Sadigh, S. (2026) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqag080 · Cited by 1
Cell Cycle Regulation in Brain Construction
Crespo, M., & Ross, M. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397265-1.00094-0 · Cited by 1
Catecholamines inhibit gastric epithelial [RGM-1] cell proliferation via β adrenoceptors.
Olaleye, S. B., Wu, K., & Cho, C. H. (2010) · PubMed · Cited by 1
Regulation of Pre-RC Assembly: A Complex Symphony Orchestrated by CDKs
McClendon, A. K., Dean, J. L., & Knudsen, E. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1770-6_3 · Cited by 1
“Additionally, while CDK2 nullfibroblasts were shown to undergo normal cell cycles ( Sherr and Roberts, 2004 ), cyclin E null cells fail to progress from quiescence to S phase due to a defect in Mcm protein loading (Geng et al., 2003).”
BackgroundLoyer, P., & Corlu, A. (2011) · InTech eBooks · doi:10.5772/19631 · Cited by 1
“Independently, the demonstration was brought that knockout mice for Cdk2 as well as for E-type Cyclins are viable and that the cell cycle of cultured Cdk2-/- mouse embryonic fibroblasts (MEFs) did not show major alterations (Berthet et al., 2003; Ortega et al., 2003; Sherr and Roberts, 2004).”
Assessing uncertainty in model parameters based on sparse and noisy experimental data
Hiroi, N. F., Swat, M. J., & Funahashi, A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00128 · Cited by 1
“ORIGINAL RESEARCH ARTICLE published: 04 April 2014 doi: 10.3389/fphys.2014.00128 Assessing uncertainty in model parameters based on sparse and noisy experimental data”
BackgroundInfluentialRecurrent Giant Sarcoma of the Anterior Abdominal Wall
Doran, H. (2012) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000176 · Cited by 1
Progenitor Cells and Cardiac Homeostasis
Leri, A., Hosoda, T., Rota, M., Bearzi, C., Urbanek, K., Bolli, R., Kajstura, J., & Anversa, P. (2007) · Elsevier eBooks · doi:10.1016/b978-012370615-7/50041-x · Cited by 1
Bayleyegn, Y. N., & Govinder, K. S. (2016) · Mathematical Methods in the Applied Sciences · doi:10.1002/mma.4213 · Cited by 1
“CycE associates with Cdk2 and serves a dual purpose in activating cell proliferation: (i) It phosphorylates and thereby activates protein that promotes cell division such as Cdc25A [14–17] and (ii) it phosphorylates and thereby inhibits protein that impedes cell progression such as P27Kip1 [14, 17].”
BackgroundSakao, M., Sakaguchi, Y., Suzuki, R., Takahashi, Y., Kishimoto, M., Fukui, T., Uchida, K., Nishio, A., Matsuzaki, K., & Okazaki, K. (2017) · Pancreas · doi:10.1097/mpa.0000000000000759 · Cited by 1
Targeting the CDK4/6 Pathway in Breast Cancer
Malorni, L., Migliaccio, I., Guarducci, C., Bonechi, M., & Leo, A. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-48848-6_69 · Cited by 1
Haghighi, M. M., Vahedi, M., & Mojarad, E. N. (2017) · Gastroenterology and hepatology from bed to bench. · Cited by 1
The Role of the AMPK Pathway in ZEA-induced Cellcycle Arrest in Rat Sertoli Cells.
Chen, Y. L., Chen, Y. F., Feng, N. N., Liu, Z., & Bian, J. C. (2019) · PubMed · doi:10.3967/bes2019.120 · Cited by 1
3,6-diazabicyclo[3.3.1]heptanes Induces Apoptosis and Arrests Cell Cycle in Prostate Cancer Cells
Wei, H.-J., Lian, W., & Wang, C. (2020) · Medical Science Monitor · doi:10.12659/msm.920266 · Cited by 1
“Generally, a gap phase between G1 and S phases regulates progression of cells from one cell cycle to another and the process is under the control of intracellular and extracellular signals [19,20].”
BackgroundComprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitors
Pacureanu, L. M., Avram, S. I., & Crisan, L. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1747544 · Cited by 1
Payne, E. M., & Look, A. T. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10008-1 · Cited by 1
Mori, K., Oshima, Y., Nose, K., & Shibanuma, M. (2009) · Springer eBooks · doi:10.1007/978-4-431-88663-1_15 · Cited by 1
Cell polarity and initiation of migration
Hayashi, K., Sekine, K., Tabata, H., & Nakajima, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814407-7.00013-4 · Cited by 1
Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells
Xing, X., Liu, M., Wang, X., Guo, Q., & Wang, H. (2023) · Oncology Reports · doi:10.3892/or.2023.8483 · Cited by 2
“This includes cyclin E, which binds to CDK2, with the formed complex further phosphorylating RB to create a positive feed‐ back loop (37,38,40).”
BackgroundCDk Inhibitor for Treatment of Breast Cancer
Mir, M. A., Gul, A., Sofi, S., & Khan, M. S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_15 · Cited by 1
Cell Cycle, DNA Damage Repair Systems, and Impact of Redox Regulation in Cancer
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_8 · Cited by 2
Ornelas, I. M., Silva, T. M., Pereira, M. R., França, G. R., & Ventura, A. L. M. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09982-7 · Cited by 1
“Moreover, IGF-1 treatment increases the expression of cyclin D1, cyclin E and CDK2, proteins that increase and accumulate during G1 phase of the cell cycle [46].”
Ho, C. N. Q., Sơn, H. N., Nguyen, H. H., Nguyen, H. T. M., Truong, H. T., Nguyen, Q. T. T., Ly, C. N., & Long, L. T. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102460 · Cited by 1
Hu, C., Jiang, Y., Ma, C., Xu, F., Cui, C., Du, X., Chen, J., Zhu, L., Yu, S., He, X., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073341 · Cited by 1
“Cdk2 and cyclin E formed a complex that co-phosphorylates substrate factors to propel the cell through the G1/S checkpoint and successfully into the S phase [42].”
Cell cycle control by components of cell anchorage
Gad, A. K. B. (2005) · Figshare · Cited by 1
Regulation of the Liver Cell Mass
Malek, N. P., Rudolph, K. L., & Diehl, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2e · Cited by 1
Pramanik, K., Trüpschuch, S., Greiner, A., Ruthardt, M., Henschler, R., & Müller, A. M. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.09.014 · Cited by 1
Ray, J. (2011) · TSpace (University of Toronto) · Cited by 2
Tang, P. (2018) · TSpace (University of Toronto) · Cited by 1
Hong, Y., He, W., Zhang, J., Shen, L., Yu, C., Yan, L., Chen, H., Wu, Y., Chen, L., Lyu, J., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-125333/v1 · Cited by 1
“Meanwhile, many studies reported that Cyclin D-CDK4/6 complexes are often overexpressed in various cancers(4-6).”
BackgroundMitogenic and Metabolic signals regulate mTOR complex 1 function to control GSK3β nuclear program
Bautista, S. J. (2021) · doi:10.32920/ryerson.14654061.v1 · Cited by 1
Pradubyat, N. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.33 · Cited by 1
Androgen Regulation of the Cell Cycle in Prostate Cancer
Huang, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_14
Su, Y. (2008) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Järviluoma, A. (2007) · Helda - University of Helsinki Institutional Repository
p16INK4A – Connecting Cell Cycle Control to Cell Death Regulation in Human Leukemia
Obexer, P., Hagenbuchner, J., & Michael, J. (2011) · InTech eBooks · doi:10.5772/25284
Protein Biosynthesis, Modifications and Degradation
Jahn, M., Jahn, D., Wünschiers, R., Ries, S. J., & Dersch, P. (2012) · Wiley eBooks · doi:10.1002/9781118657072.ch4
de Mendonça, P. O. R. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2012.tde-17042013-084156
Restrictions in the proliferative potential of inner ear hair cells and supporting cells
Loponen, H. (2012) · Helda - University of Helsinki Institutional Repository
Asprino, P. F. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2006.tde-05092006-161414
Analysis of cyclin dependent kinases in Leishmania
Gomes, F. C. (2007) · Enlighten: Theses (The University of Glasgow)
Disruption of Cell Cycle Machinery in Pancreatic Cancer
Kennedy, S., Berrett, H. R., & Robert, J. (2012) · InTech eBooks · doi:10.5772/28660 · Cited by 1
Massaro, R. R. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2009.tde-29092009-154905 · Cited by 2
Matos, T. G. D. F. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2007.tde-23112007-105248 · Cited by 4
Mecanismos moleculares que regulan la activación clásica y alternativa en los macrófagos
Toribio, L. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.